Reading a Horse Chestnut COA: Aescin Assay and Impurity Checks

September 23, 2026

When sourcing botanical ingredients for supplement or cosmetic formulations, the Certificate of Analysis (COA) is your first line of quality verification. For horse chestnut extract powder, two parameters matter most: the Aescin assay result and the impurity profile. Aescin, the primary triterpenoid saponin group in Aesculus hippocastanum seed extract, is an important marker for standardizing the material. Understanding how to read these numbers accurately helps procurement teams avoid costly sourcing errors and supports consistent product documentation for different markets.

Understanding the Basics of Horse Chestnut Extract Powder Quality

What Makes Aescin the Defining Marker

Aescin, which is sometimes written as Escin, is a complex mixture of triterpene saponins obtained from horse chestnut seeds. It is commonly used as a marker for standardizing horse chestnut extract. If you don't know the exact amount of Aescin in the extract, a COA provides limited information for comparing the material against your formulation specification.

Standard COA Sections to Review First

A COA from a professional supplier usually lists the following information about this extract: the assay method (HPLC or UV), identification tests, loss on drying, heavy metal limits, residual solvents, microbial count, and aflatoxin screening where applicable. Each section addresses a different quality or documentation requirement. You run the risk of finding information gaps if you skip any of them, especially when the ingredient is intended for US or European markets.

Aesculus chinensis Bgehorse chestnut extract powder

Why Testing Method Matters from the Start

The reported content of Aescin-related components depends on the analytical method used. When UV spectrophotometry is used to estimate total saponins, it may produce higher values than a method that separates individual components. A batch that says "20% Aescin by UV" should therefore not automatically be treated as equivalent to a batch that says "20% Aescin by HPLC." Before comparing suppliers, you should always confirm which method was used and what the reported percentage actually represents.

How to Read and Interpret the Aescin Assay in a COA

Typical Assay Ranges and What They Mean

By HPLC, commercial standardized horse chestnut seed extracts may be offered around the commonly specified Aescin range, depending on the supplier, extraction process, and specification. Low results may indicate differences in raw material or processing, but they should be evaluated against the agreed product specification rather than treated as proof of poor quality. Values outside the expected range should lead to additional checks, particularly when the analytical method differs between suppliers.

Factors That Influence Assay Results

Aescin content can be affected by raw-material origin, harvest conditions, extraction process, and storage conditions. Over time, batches of horse chestnut extract powder that are exposed to unsuitable moisture, heat, or packaging conditions may show changes in physical or analytical characteristics. When reviewing a COA, make sure the manufacture date, retest date where applicable, and storage instructions are compared so that the documentation is current and traceable.

​​​​​​​Red Flags in Assay Reporting

Be wary of COAs that don't list the testing method, reference standard, or relevant testing date. These gaps make it harder to determine how the reported result was generated or whether it applies to the specific batch. A transparent provider should identify the analytical method and reference basis used to obtain the result and should be able to explain the testing procedure when requested.

Impurity Checks in Horse Chestnut Extract Powder COA: Ensuring Safety and Compliance

The Critical Role of Aesculin Removal

Aesculin is a hydroxycoumarin glycoside associated with horse chestnut material and may be relevant to quality control depending on the intended specification and application. A suitable COA can include an HPLC test or other appropriate analytical information showing the level of aesculin against the agreed specification. Suppliers that do not provide relevant testing information should be asked for additional documentation or clarification before the material is approved.

These are the main types of impurities that should be considered for horse chestnut extract powder:

  • Residual solvents: Extraction residues from solvents used during processing should be controlled according to the applicable specification and intended market. Relevant requirements may reference ICH Q3C or other recognized standards where applicable.
  • Heavy metals: Elements such as lead, arsenic, cadmium, and mercury should be controlled according to the requirements applicable to the product category and destination market. Independent ICP-MS testing can provide additional analytical verification when needed.
  • Aflatoxins: Aflatoxin B1 and total aflatoxin may need to be evaluated according to the requirements applicable to the raw material and finished product. Mycotoxin testing can be relevant for botanical materials because contamination risk depends on sourcing, handling, and storage.
  • Microbial agents: Total aerobic microbial count, yeast, mold, E. coli, Salmonella, and other relevant microorganisms should be evaluated against the agreed specification and applicable standard.

These conditions should be assessed according to the intended US, EU, or other target market rather than treated as one universal set of limits. If a COA doesn't contain relevant sections for your product specification, it should prompt a procurement review and a request for supporting documentation.

Comparing COAs from Multiple Suppliers

Beyond Aescin: Other Parameters That Matter

When comparing COAs for horse chestnut extract powder from different suppliers, you should look at more than just the Aescin %. When it comes to industrial compatibility, particle size, moisture content, and bulk density can all play a role. Depending on your market and label needs, organic certification, kosher/halal status, and country of origin may also be important. Physicalhorse chestnut extract powder specifications should be matched to the actual requirements of your manufacturing process rather than treated as universal values.

Matching COA Data to Your Technical Requirements

The choices you make about purchases should be based on COA information that fits your unique formulation needs. A cosmetic serum may require suitable dispersion and appearance characteristics, while an oral supplement capsule may have different particle-size and flow requirements. Before you place a bulk order, you can get a fuller picture by asking for a technical data sheet along with the COA.

Using COA Data in Supplier Negotiations

COA data gives you bargaining power based on facts, not assumptions. Comparative COA analysis can show differences in assay, testing scope, physical specifications, and documentation quality when two suppliers offer similar prices. Suppliers who provide records of consistency from batch to batch and optional independent verification can give buyers more information when assessing long-term supply arrangements.

Best Practices for Consistent Quality in Bulk Purchases

Integrate COA Review into Your Procurement Workflow

Before goods are accepted, the COA should be reviewed for every major purchase. Set internal pass/fail conditions for physical factors, impurity limits, and the Aescin assay range. Your QA team should make sure that the batch number on the COA matches the number on the shipping label and that the document is complete, traceable, and appropriately authorized.

Third-Party Lab Validation Adds a Layer of Confidence

Third-party retesting on a risk-based or periodic basis, even when supplier COAs look complete, can provide additional analytical confidence. Send representative samples to a recognized ISO/IEC 17025 laboratory when independent confirmation of Aescin content, elemental impurities, or other parameters is required. This approach can be useful for supplier qualification, periodic verification, and higher-risk raw materials.

Monitor Supplier Performance Over Time

Keep track of COA findings for more than one batch. A reliable supplier should be able to maintain the agreed Aescin specification and relevant impurity controls within defined ranges. Differences between batches can occur, but repeated or unexplained inconsistency in assay, moisture, or impurity results should be investigated before it affects the quality of the finished product.

Conclusion

It takes more than just reading a single number to evaluate a COA for plant extracts. The three most important areas for checking the quality of horse chestnut extract powder are the Aescin assay method, the completeness of the impurity panel, and batch-to-batch consistency. When procurement teams treat COA review as a planned process rather than a formality, they are better able to identify ingredients that fit their formulation specifications and provide the documentation needed for market-specific quality review.

certification

FAQ

1. What is the difference between UV and HPLC Aescin testing?

UV methods may estimate total saponins or related components and can therefore produce different values from HPLC methods designed to separate and quantify specific Aescin-related components. When asking for a COA, you should always specify the analytical method and confirm exactly what the reported percentage represents so that supplier quotations and specifications can be compared fairly.

2. How do I confirm that aesculin has been removed?

A suitable COA can include a specific HPLC test or other validated analytical information for aesculin, depending on the product specification. If this information isn't provided, you should ask the supplier for supporting test data or consider independent testing before approving the batch for your intended application.

3. How often should I request updated COA documentation?

For each production batch, ask for a new batch-specific COA. The appropriate shelf life of an Aescin-standardized extract depends on the material, packaging, storage conditions, and supplier stability data. Batch-specific documentation is important for traceability and for confirming that the delivered material matches the agreed specification.

4. Can this extract be used in aqueous cosmetic formulations?

The suitability of horse chestnut extract powder for an aqueous cosmetic formulation depends on the specific grade, concentration, particle characteristics, formulation system, and processing conditions. For clear serums or water-based systems, ask the supplier for relevant dispersion or solubility data and, where necessary, request a grade specifically developed for the intended application rather than assuming that all standardized extracts behave the same way.

Request a Verified COA from Angelbio — Trusted Horse Chestnut Extract Powder Supplier

Angelbio provides standardized plant extracts to companies around the world that make nutraceuticals, cosmetics, and functional products. With over 18 years of R&D experience, Angelbio offers horse chestnut extract powder with batch-specific COA documentation, analytical testing support, and technical product information. Buyers can request a sample COA, product specification sheet, or bulk pricing to evaluate the material against their formulation and procurement requirements. Contact our team at angel@angelbiology.com.

exhibition

References

1. European Medicines Agency. Assessment Report on Aesculus hippocastanum L., Semen. EMA/HMPC, 2012.

2. Pittler, M. H., & Ernst, E. "Horse chestnut seed extract for chronic venous insufficiency." Cochrane Database of Systematic Reviews, 2012.

3. United States Pharmacopeia. USP General Chapter <2021>: Microbial Examination of Nonsterile Products. USP, 2023.

4. European Commission. Commission Regulation (EC) No 1881/2006: Setting Maximum Levels for Certain Contaminants in Foodstuffs. Official Journal of the European Union, 2006.

5. International Council for Harmonisation. ICH Q3C: Guideline for Residual Solvents. ICH, 2021.

6. Sirtori, C. R. "Aescin: Pharmacology, pharmacokinetics and therapeutic profile." Pharmacological Research, 2001.

Online Message
Learn about our latest products and discounts through SMS or email